The long-term oncologic outcome for patients with Low and intermediate risk prostate cancer with transurethral resection who were treated using low-dose-rate (LDR) prostate brachytherapy

Detalle

Muñiz A., Kannemann A., García Blanco A.S., Anchuelo J., Ferri M., Cardenal J., Sánchez J., P. Prada. The long-term oncologic outcome for patients with Low and intermediate risk prostate cancer with transurethral resection who were treated using low-dose-rate (LDR) prostate brachytherapy. Poster. XVIII Congreso Nacional de Oncología Radioterápica (SEOR). Valencia, Junio 2015.